Agios Pharmaceuticals
AGIO
#5028
Rank
NZ$3.33 B
Marketcap
NZ$55.68
Share price
6.70%
Change (1 day)
-24.28%
Change (1 year)

Agios Pharmaceuticals (AGIO) - Total liabilities

Total liabilities on the balance sheet as of June 2026 : NZ$0.14 Billion

According to Agios Pharmaceuticals 's latest financial reports the company's total liabilities are NZ$0.14 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Agios Pharmaceuticals - Total liabilities on balance sheet (from 2012 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31NZ$0.19 B-8.2%
2022-12-31NZ$0.21 B1.78%
2021-12-31NZ$0.21 B-66.04%
2020-12-31NZ$0.62 B69.15%
2019-12-31NZ$0.37 B45.8%
2018-12-31NZ$0.25 B-24.25%
2017-12-31NZ$0.33 B-10.56%
2016-12-31NZ$0.37 B243.43%
2015-12-31NZ$0.10 B27.04%
2014-12-31NZ$86.19 M1.59%
2013-12-31NZ$84.84 M-25.04%
2012-12-31NZ$0.11 B-32.74%
2011-12-31NZ$0.16 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Pfizer
PFE
NZ$205.18 B 140,233.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$191.28 B 130,721.69%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$125.53 B 85,756.22%๐Ÿ‡ฌ๐Ÿ‡ง UK
Xencor
XNCR
NZ$0.39 B 169.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
NZ$1.20 B 724.80%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$9.58 B 6,455.28%๐Ÿ‡บ๐Ÿ‡ธ USA